Medical Capability Explainer · Health Check & Advanced Diagnosis
Beyond a Single Blood Test: What Continuous Glucose Monitoring Can Reveal About Metabolic Risk
A large Chinese cohort describes glucose patterns and digital risk stratification—not proof that CGM should be used for everyone.
Review draft · Evidence checked · Not published
Beyond a single blood test
A fasting glucose result or HbA1c measurement can provide valuable information about metabolic health. But blood glucose also changes throughout the day, after meals, during sleep and in response to activity and medication. Continuous glucose monitoring (CGM) records glucose patterns over time, offering a different view of how the body responds.
In October 2026, researchers published a large Chinese cohort analysis in npj Digital Medicine examining whether these patterns could help characterize diabetes and stratify complication risk. The study adds to an important question for preventive healthcare: how can data help clinicians move from a single result to a more complete assessment?
What did the iCanNet study examine?
The researchers analyzed the iCanNet cohort of 90,757 participants. They examined 48 metrics derived from CGM data, compared patterns across people with normal glucose regulation, prediabetes, type 2 diabetes and type 1 diabetes, and explored digital risk scores for complications among people with type 2 diabetes.
The analysis found distinct glucose-monitoring patterns across these groups. It also explored combinations of measures that may capture risk information beyond one conventional metric. This is a research finding about characterization and risk stratification—not evidence that using CGM for everyone will prevent diabetes or improve long-term health outcomes.
How might CGM fit into a health check?
A conventional health check may include fasting glucose, HbA1c, blood pressure, lipids, weight and other tests chosen according to the patient's history. CGM adds repeated measurements over time. This can be especially useful in established diabetes care, where clinicians may use the information to understand fluctuations, hypoglycemia and treatment response.
For people without diabetes, however, the appropriate role of CGM is less settled. The fact that a device produces detailed data does not automatically mean that it should be included in every executive or general health check. Clinical context, the reason for testing, interpretation, cost and potential overdiagnosis all matter.
More data still requires clinical interpretation
More data can create better questions, but it can also create confusion. A glucose graph is useful only when a qualified clinician can interpret it alongside symptoms, medications, medical history and established diagnostic tests.
The 2026 study focuses on the structure of glucose patterns and risk models. Before a digital risk score can become a standard clinical decision tool, its performance, generalizability, clinical utility and impact on outcomes need appropriate validation.
Planning a patient-specific evaluation
The most valuable health check is not necessarily the one with the most tests; it is the one designed around a person's actual risk factors and followed by clear recommendations. A practical pathway might begin with a review of age, family history, symptoms, prior blood results, medications and health goals. A clinician can then recommend appropriate tests and explain whether additional monitoring has a role.
Explore health checks in China for international patients, understand advanced diagnostic coordination, and use the foreign-patient access guide to prepare records and questions.
MedVoyage China coordinates access to healthcare services and helps international patients prepare information, organize appointments and understand the sequence of care. We do not prescribe glucose-monitoring devices or provide medical diagnoses. Whether CGM is appropriate must be decided by the treating clinician.
Questions & answers
Does everyone need continuous glucose monitoring?
No. Its role depends on the patient's condition and clinical objectives.
Can CGM replace HbA1c or standard diabetes tests?
No. It provides complementary information and should be interpreted with established clinical assessments.
Does the 90,757-person study prove CGM prevents complications?
No. It studied associations, patterns and risk stratification, not a randomized intervention demonstrating prevention.
Primary source
- Lu J, Ding Y, Zhao B, et al. npj Digital Medicine. Published 13 October 2026.Multidimensional continuous glucose monitoring metrics enable digital risk stratification across the diabetes spectrum